If youre already prescribing, or considering it, the question is the same: how do you operate compliantly while the legal pathway is still being built
Arakawa M, Mita T, Azuma K et al (2010) Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like
En el mbito dermatolgico, sus efectos en el rejuvenecimiento de la piel son notables, estimulando la produccin de colgeno y elastina , protenas esenciales para la estructura y firmeza cutnea
Clinical practice should increasingly focus on: Body composition assessment Adequate protein intake Resistance exercise Strategies to preserve skeletal muscle during weight loss #GLP1 #Obesity #Sarcopenia #ClinicalNutrition #BodyComposition #MuscleHealth #ObesityMedicine To view or add a comment, sign in I think we will have a frailty problem in the future, especially with the cyclic use of these meds
In 2024, Metaphore and Novo Nordisk announced a collaboration to create a portfolio of novel research programs to develop transformational medicines, including new therapies for obesity management
Immunol, 109, 867872